Arcadia Investment Management Corp Axonics, Inc. Transaction History

Arcadia Investment Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$49.38 - $63.75 $51,256 - $66,172	-1,038 Reduced 51.06%	995 $61,000
Q3 2023 Oct 23, 2023	BUY	$48.64 - $62.51 $4,864 - $6,251	100 Added 5.17%	2,033 $114,000
Q2 2023 Jul 24, 2023	BUY	$47.99 - $60.21 $11,565 - $14,510	241 Added 14.24%	1,933 $97,000
Q1 2023 May 05, 2023	BUY	$52.6 - $67.34 $25,300 - $32,390	481 Added 39.72%	1,692 $92,000
Q4 2022 Feb 08, 2023	BUY	$59.56 - $76.6 $72,127 - $92,762	1,211 New	1,211 $75,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Arcadia Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Arcadia Investment Management Corp with notifications on news.